Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, ...

DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

In the latest trading session, Humacyte, Inc. (HUMA) closed at $1.05, marking a -13.93% move from the previous day. This move lagged the S&P 500's daily loss of 0.33%. Meanwhile, the Dow gained 0.1%, ...

How the DoD funding move ties into Humacyte’s investment story The latest U.S. Department of Defense appropriations and authorization bills set aside funding to assess biologic vascular repair ...

DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...

Humacyte (HUMA), a clinical-stage biotech firm developing implantable human tissue, is set to announce its third-quarter financial results on November 8, 2024. The company, known for its acellular ...

Management reiterated that the majority of first-year Symvess sales are expected in the second half of 2025, linked to the timing of VAC approvals. Niklason stated, "We have consistently forecast that ...

(RTTNews) - Humacyte, Inc. (HUMA) has launched Symvess, a bioengineered vascular conduit for adults needing urgent revascularization due to extremity arterial injury when autologous vein grafts aren't ...

Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for its flagship SYMVESS product ...

Symvess' limited indication and safety concerns restrict its commercial potential, and early revenue doesn't reflect true clinical adoption. Humacyte's cost-cutting and recent $46.7M stock offering ...